Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First
Similar News
expand_more
2 w.
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
Science
12 h.
«Jusqu'à 30 ans de plus à profiter de la vie» : le «biohacking» peut avoir des effets positifs
Science
Technology
Science
Science